Pre-mRNA splicing, short intron, polypyrimidine tract, SPF45 (RBM17), U2AF heterodimer, U2 snRNP, SF3b155 (SF3b1), U2AF-homology motif (UHM), UHM-ligand motif (ULM) depleted SPF45 protein ( Fig. 1, middle panel) . To test if SPF45 might have a general role in splicing of short introns, we assayed two other endogenous pre-mRNAs targeting the 70-nt (intron 9 of RFC4) and the 71-nt (intron 17 of EML3). Both introns were also markedly repressed in SPF45-depleted HeLa cells ( Fig. 1 , right 2 panels).
Human pre-mRNA introns vary in size from under fifty to over a million nucleotides. We searched for specific splicing factors involved in human short introns by screening siRNAs against 154 human nuclear proteins for activity on a model short 56-nucleotide intron-containing HNRNPH1 pre-mRNA.
We identified a known alternative splicing regulator SPF45 (RBM17) as a general splicing factor that is essential to splice out this 56-nt intron.
Wholetranscriptome sequencing of SPF45 deficient cells revealed that SPF45 is specifically required for the efficient splicing of many short introns. Our crosslinking and biochemical analyses demonstrate that SPF45 specifically replaces the U2AF heterodimer on the truncated polypyrimidine tracts. To initiate splicing, the U2AF-homology motif (UHM) of the replaced SPF45 interacts with the UHM-ligand motif (ULM) of the U2 snRNP protein SF3b155 (SF3b1). We propose the existence of a distinct subset of SPF45-dependently spliced short introns.
There is a remarkable pattern in the distribution of higher eukaryotic pre-mRNA intron length; most introns fall either within a narrow peak under one hundred nucleotides or in a broad distribution peaking around several thousand nucleotides and extending to over a million nucleotides [1] [2] [3] . Pre-mRNA splicing is a ubiquitous and essential part of eukaryotic gene expression, however, little is known about any specific mechanisms for the precise recognition of the degenerated 5¢ and 3¢ splice site sequences within such extensively varied length of introns.
The basic splicing mechanism was studied and established using model pre-mRNAs with a single relatively short intron of a few hundred nucleotides, which are efficiently spliced in cells and in vitro 4, 5 . According to such optimal systems, the essential splicing sequences in pre-mRNA, namely the 5′ splice site, the branch-site sequence, and the polypyrimidine tract followed by the 3′ splice site, are simultaneously bound by the splicing factors U1 snRNP, U2 snRNP, and U2AF heterodimer (U2AF 65 /U2AF 35 , U2AF2/U2AF1 as HGNC approved symbol), respectively, leading to early formation of the spliceosomal E and A complexes (reviewed in Ref. 6 ). Under the electron microscope, the A-complex is an asymmetric globule is an asymmetric globule (~26 × 20 × 19.5 nm) 7 that fully occupies 79-125 nucleotides (nt) of RNA 8 , and recent high-resolution cryo-electron microscopy structure of A-complex is consistent with this notion (reviewed in ref. 9 ). Whereas human ultra-short introns under those lengths (43-65 nt) are indeed spliced 10, 11 ; this raises the question of how ultra-short introns can be recognized and spliced by the 'oversized' A complex without steric hindrance.
To approach this problem, we hypothesized that a general splicing factor must be specifically involved in splicing of pre-mRNAs with short introns.
Results
SPF45 is a novel essential splicing factor for a subset of short introns. To find potential factors involved in splicing of short introns, we screened an siRNA library targeting 154 human nuclear proteins for splicing activity of the HNRNPH1 pre-mRNA including 56-nt intron 7 10, 11 . Many known RNA-binding proteins and splicing factors could be tested with this siRNA library (Table S1 ).
HeLa cells were transfected with each siRNA and recovered total RNAs were analyzed by RT-PCR to examine splicing activity of the endogenous HNRNPH1 pre-mRNA with 56-nt intron (Fig. 1, left panel) . The strongest splicing repression was markedly caused by knockdown of SPF45 (RBM17 as HGNC approved symbol; right panel) that indeed effectively fragment in the AdML intron (192 nt). Interestingly, this chimeric pre-mRNA with the short HNRNPH1 PPT remained SPF45 dependent ( Fig. 3 , 'AdML 5′MT'). All these results demonstrate that short PPT per se in the HNRNPH1 intron 7 is the determinant for the SPF45dependency in splicing.
All of these results were nicely recapitulated in the distinct SPF45-dependent EML3 pre-mRNA including 71-nt intron ( Supplementary Fig. S3a ). Moreover, our global PPT length analysis of the retained introns in SPF45-depleted cells showed that PPT lengths of SPF45dependent short introns (<100 nt) were significantly shorter than those of the whole RefGene introns ( Supplementary Fig. S3b ). Together, we conclude that it is the truncated PPTs in short introns that are crucial for the SPF45 function in splicing.
SPF45 replaces U2AF 65 on truncated PPTs in short introns to promote splicing. In an early transition of human spliceosome from the E to A complexes, the branch site, PPT and the 3′ splice site are bound cooperatively by SF1, U2AF 65 and U2AF 35 , respectively. A stable U2 snRNP-associated splicing complex is then formed by ATP-dependent displacement of SF1, contact of p14 (U2 snRNP associated factor) with the branch site, and interaction of U2AF 65 with the U2 snRNP component SF3b155 (reviewed in ref. 6 ). Since splicing activity of SPF45 depends on short PPTs, we hypothesized that insufficient U2AF 65 binding to a truncated PPT would allow its replacement by SPF45.
To examine whether SPF45 associates with short introns, mini-genes encoding HNRNPH1, EML3, MUS81, and control AdML introns, were expressed in HeLa cells. We confirmed that these mini-genes were spliced in an SPF45-dependent manner ( Fig. 3 and Supplementary Fig.  S4 ) as we observed in these endogenous genes (Figs. 1 and 2c), so we proceeded to analyze proteins associated with these ectopically expressed RNAs.
We used formaldehyde crosslinking to detect any indirect RNA association of SPF45 12 . HeLa cells were co-transfected with the four mini-genes and Flag-SPF45 expression plasmid, crosslinked with formaldehyde, immunoprecipitated with anti-FLAG antibody, and the coprecipitated RNAs were analyzed by RT-qPCR ( Fig. 4a ). SPF45 bound to all pre-mRNAs derived from these four mini-genes irrespective of the length of the introns. The binding of SPF45 to control AdML intron (231 nt) is consistent with previous proteomic detection of SPF45 in the human spliceosome 13 . SPF45 was also detected on MINX (131 nt) and PM5 (235 nt) introns 14, 15 (reviewed in ref. 6 ).
We next examined the binding of U2AF 65 and SF3b155 to pre-mRNAs by UV crosslinkingimmunoprecipitation (CLIP).
Whole-cell extracts from crosslinked cells were immunoprecipitated with anti-U2AF 65 and anti-SF3b155 antibodies, and the precipitated RNAs were analyzed by RT-qPCR ( Fig. 4b ). SF3b155 bound to all the pre-mRNAs, while significant U2AF 65 binding was observed only with control AdML pre-mRNA and it was very weak with the three SPF45-dependent short introns.
We biochemically verified the binding of U2AF 65 and SF3b155 to the HNRNPH1 intron and control AdML intron by affinity pull-down assay using biotinylated pre-mRNAs ( Fig. 4c ). In agreement with crosslinking experiments, SPF45 bound to both AdML and HNRNPH1 pre-mRNAs; however, importantly, U2AF 65 strongly bound to AdML pre-mRNA and only bound to HNRNPH1 pre-mRNA when SPF45 was depleted from nuclear extracts. These results together support our proposed hypothesis that SPF45 replaces U2AF 65 that is unstably bound to truncated PPTs of short introns.
We noticed that endogenous U2AF 65 -knockdown barely repressed splicing of the SPF45dependent short intron ( Supplementary Table S1 , No. 142; Supplementary Fig. S5a ). Therefore, we checked splicing efficiencies of these four mini-genes in U2AF 65 -knockdown HeLa cells ( Fig. 5 ). This depletion of U2AF 65 also caused effective co-depletion of U2AF 35 ( Fig. 5 , left panel) that is consistent with previous reports 16, 17 . In the control AdML mini-gene, spliced mRNA was reduced by the depletion of U2AF 65 , showing that U2AF heterodimer is essential for conventional AdML pre-mRNA splicing as expected. Remarkably, splicing of SPF45-dependent pre-mRNAs with short introns was rather activated by the depletion of U2AF 65 (Fig. 5 , right 3 panels).
In endogenous SPF45-dependent pre-mRNAs ( Supplementary Fig. S5a ), such marked activation was not observed that could be due to the almost saturated efficiency of splicing (see amounts of unspliced pre-mRNAs). Taken together, we conclude that SPF45 effectively competes out U2AF heterodimer on truncated PPTs and the newly installed SPF45 promotes splicing of pre-mRNAs with short introns.
SF3b155-U2AF 65 /U2AF 35 is displaced by SF3b155-SPF45 via ULM-UHM binding. The SPF45 protein contains a G-patch motif for the interactions with nucleic acids and proteins 18, 19 , and C-terminal U2AF-homology motif (UHM) that binds the UHM-Ligand motifs (ULM) of its partner proteins. The binding between the UHM and the ULM plays an essential role in the splicing reactions; e.g., interactions of U2AF 65 -SF3b155 (SF3B1 as HGNC approved symbols) component of U2 snRNP, U2AF 65 -U2AF 35 , and U2AF 65 -SF1 (Reviewed in ref. 20 and references there in). Remarkably, in vitro binding analyses using the purified recombinant proteins showed that SPF45-UHM can bind to SF3b155-ULM, U2AF 65 -ULM, and SF1-ULM with low micromolar affinity 21 . We therefore postulated that the SF3b155-U2AF 65 /U2AF 35 complex is remodeled to the SF3b155-SPF45 complex by switching of their ULM-UHM interactions and truncated pyrimidine tract can be recognized through the G-patch motif of SPF45 (see Fig. 8 ).
To test our hypothesis, we first examined the binding of SPF45 to SF3b155. We prepared E. coli recombinant glutathione S-transferase (GST)-fusion proteins of SPF45, its D319K mutant in the UHM (SPF45/UHMmt) that no longer binds any ULM, and G patch motif-deleted mutant (SPF45/∆G) that loses potential interaction with nucleic acids and proteins 21 ( Supplementary Fig. S6a ). Our GST pull-down assays demonstrated that GST-SPF45 bound to SF3b155, but not to SF1, with crude nuclear extracts under physiological conditions even though both SF3b155 and SF1 contain ULM ( Fig. 6a ). As expected for the SPF45-SF3b155 interaction, the UHM of SPF45 is essential ( Fig. 6a , 'GST-SPF45/UHMmt') while the G patch of SPF45 is not required ( Fig. 6a , 'GST-SPF45/∆G'), demonstrating the ULM-UHM interactions in the SF3b155-SPF45 complex. GST-SPF45 also binds to two other previously suggested SPF45-partner proteins that lack ULMs: spliceosomal A complex protein, SF4 (SUGP1 as HGNC approved symbol) and DEAH helicase protein of the U2-related group, hPRP43 22 . However, we confirmed that these two SPF45 interacting factors are not relevant to splicing of short introns ( Supplementary Fig. S5b, c) .
The binding between U2AF 65 -ULM and U2AF 35 -UHM is extremely strong 23 . Remarkably, GST-SPF45 did not pull-down U2AF 65 and U2AF 35 in crude nuclear extracts ( Fig. 6a ). These data together indicate that the U2AF 65 -ULM cannot interact with the SPF45-UHM and thus the SPF45-UHM and U2AF 65 -UHM compete for a functional binding toward the SF3b155-ULM (see Fig. 8 ). Therefore, we next investigated the competitive binding of U2AF 65 and SPF45 toward SF3b155 by titrating the dose of GST-SPF45 in the immunoprecipitation assays ( Fig. 6b ). GST-SPF45 interfered with the binding between SF3b155 and U2AF 65 in a dosedependent manner, however, GST-SPF45/UHMmt did not disturb this binding. These results indicate that the SPF45-UHM competes with that of U2AF 65 -UHM for the SF3b155 binding.
Finally, we examined whether the SPF45-SF3b155 interaction and the G-patch of SPF45 are essential for the SPF45-dependent splicing on short introns. We performed functional rescue experiments with SPF45-depleted HeLa cells using three siRNA-resistant proteins; SPF45 (SPF45/siR), SPF45-UHM mutant (SPF45/UHMmt/siR), and a G-patch motif-deleted SPF45 (SPF45/∆G/siR; Supplementary Fig. S6a ). We confirmed that the subcellular localization of these three mutant proteins did not change from that of endogenous SPF45 protein ( Supplementary Fig. S6b ). Protein expression levels of endogenous SPF45 and ectopically expressed three SPF45 siRNA-resistant mutants were checked by Western blotting in SPF45depleted HeLa cells ( Fig. 7 , left panel). We analyzed splicing efficiencies of three mini-genes including short introns by RT-PCR ( Fig. 7 , right 3 panels). SPF45/siR rescued the splicing defects of all short introns in SPF45-depleted HeLa cells, however the SPF45/UHMmt/siR and SPF45/∆G/siR did not (compare with control 'vector' lane). Taken together, we conclude that it is SPF45 that competes out U2AF 65 and settles on the truncated PPT to promote splicing of pre-mRNAs with short introns (Fig. 8 ).
Discussion
Over a generation ago, two different splicing mechanisms termed 'intron-definition model' for short introns and 'exon-definition model' for long introns were proposed (reviewed in ref. 24 ). In the former model, frequent lack of the PPT in vertebrate short introns was remarked and an alternative mechanism that circumvents this problem were assumed. Here we resolve this conjecture by demonstrating that a subset of human short introns, with significantly undersized pyrimidine tracts, is recognized by SPF45 but not by the U2AF heterodimer; implicating that SPF45 as a novel constitutive splicing factor in the spliceosomal complex A. This finding rationally explains why SPF45, which was previously considered just to be an alternative splicing factor, is essential for cell survival and maintenance in vivo 25 .
We eventually discover the long-sought-after factor responsible for splicing on short introns, and furthermore, we provide mechanistic details of its function. We found that both SPF45 and U2AF 65 can bind on introns with SF3b155 irrespective of intron size presumably via five ULMs in SF3b155, as previously shown in the simultaneous binding of U2AF 65 and PUF60 to SF3b155 26 .
This observation can be explained by the previous mass spectrometry analysis using AdML, MINX and PM5 pre-mRNA with conventional introns; i.e., SPF45 is contained in E, A and B complexes as a U2 snRNP-related protein [13] [14] [15] 27, 28 (reviewed in ref. 29 ). Our unique finding was that U2AF 65 needs to be expelled by SPF45 to promote splicing of a subset of short introns. Previous structural study showed that U2AF 65 binds to eight or nine nucleotides of pyrimidine tract 30, 31 . Here we propose a mechanistic model that the weak and unstable U2AF 65 binding on the truncated PPT of short intron allows access of SPF45, leading to the replacement of the U2AF heterodimer by SPF45 and its eventual placement on the truncated PPT through the Gpatch motif ( Fig. 8 ).
It was demonstrated that SPF45-depleted fruit fly (Drosophila melanogaster) S2 cells can be functionally rescued by human SPF45 32 . The SPF45-dependent splicing event on the shorter intron might be conserved in fruit fly. Interestingly, fruit fly spliceosomal B complex formed on Zeste pre-mRNA (with 62-nt intron including 14-nt PPT) contains SPF45, but that formed on Ftz pre-mRNA (with 147-nt intron including 33-nt PPT) does not 33 . Therefore, SPF45 is located exclusively in short introns in fruit fly, while in human, SPF45 exists in all introns on standby mode for short introns.
Our RNA-Seq analysis in the SPF45-knockdown cells detected the changes in alternative splicing ( Fig. 2a ). SPF45 was indeed identified and characterized as an alternative splicing regulator. In fruit fly, SPF45 interacts with Sex lethal (Sxl) protein and induces exon 3 skipping of Sxl pre-mRNA 32 . In mammals, SPF45 can cause exon 6 skipping in FAS pre-mRNA that produces soluble isoform of FAS inducing autoimmune phenotypes in mice 21 .
In the SPF45-induced regulation of alternative splicing, there was no competition between SPF45 and U2AF heterodimer on the Sxl pre-mRNA 32 . Whereas we found a competitive and mutually exclusive binding of SPF45 and U2AF heterodimer on the truncated PPT to splice out short intron. We speculate that the cooperative interaction of SPF45 and U2AF 65 with SF3b155 may be required for alternative splicing regulation, whereas, exclusive binding of SPF45 with SF3b155, but without the U2AF heterodimer, is critical for short intron-specific constitutive splicing ( Fig. 8) . Interestingly, the U2-related protein PUF60 and U2AF 65 cooperatively interact with SF3b155 to activate weak 3¢ splice sites 34 and the potential binding of both proteins to SF3b155 was demonstrated 26 . SPF45 interacts with other U2-related factors, U2SURP and CHERP, suggesting the role in alternative splicing 35 . However, our siRNA screening showed that knockdown of PUF60 and U2SURP have no effect on the splicing of hnRNPH1 short intron (Table S1, Nos. 89 and 126; unpublished data). Together, we conclude that the critical mechanism of SPF45 as a constitutive splicing factor is distinct from the mechanism of SPF45, with other interactors, as an alternative splicing factor.
Here we have just described one distinct subset of human SPF45-dependent short introns. Most recently, Smu1 and RED proteins were shown to activate spliceosomal B complexes assembled on human short introns 36 . The distance between the 5′ splice site and branch site need to be sufficiently short for Smu1/RED-dependent splicing, whereas in contrast, we clearly showed that this distance per se is not responsible for SPF45-dependent splicing ( Fig. 3 , 'AdML 5′MT'). Therefore, Smu1/Red-dependent and SPF45-dependent splicing mechanisms are essentially different, and thus they target two distinct subsets of human short introns.
The subset of SPF45-dependent short introns was identified by screening our siRNA library based on splicing activity on a 56-nt intron that contains conventional splice sites and branch site. We previously validated a list of ultra-short introns that includes remarkably atypical Grich introns with completely inefficient splice sites and branch sites, of which the 49-nt intron 12 in the NDOR1 gene and the 43-nt intron 6 in the ESRP2 gene were analyzed 10, 11 . The mechanism of splicing involved in such atypical G-rich introns is enigmatic. We assume the existence of another exotic subset of human ultra-short G-rich introns.
Methods

Construction of expression plasmids.
The mini-gene expression plasmids, pcDNA3-HNRNPH1, pcDNA3-EML3 and pcDNA3-MUS81, were constructed by subcloning the corresponding PCR-amplified fragment into pcDNA3 vector (Invitrogen-Thermo Fisher Scientific). The PCRs were performed using genomic DNA of HeLa cells and specific primer sets (Table S3 ). For the pcDNA3-AdML, the PCR was performed using the pBS-Ad2 plasmid 37 and specific primer sets (Table S3 ).
The chimeric expression plasmids, pcDNA3-HNRNPH1/5'SSAdML, pcDNA3-HNRNPH1/branchAdML, pcDNA3-HNRNPH1/3'SSAdML, pcDNA3-HNRNPH1/AdML-PPT25, pcDNA3-HNRNPH1/AdML-PPT25mt, pcDNA3-HNRNPH1/AdML-PPT13, pcDNA3-HNRNPH1/5'AdML, pcDNA3-EML3/AdML-PPT25, pcDNA3-EML3/AdML-PPT13 and pcDNA3-EML3/5'AdML were constructed from the parent plasmids by overlap extension PCR with specific primer sets (Table S3 ).
To construct expression plasmids, pcDNA3-Flag-SPF45 and pGEX6p2-SPF45, the ORF region was PCR-amplified from HeLa cells cDNA and subcloned into the pcDNA3-Flag and pGEX6p2 vectors (GE Healthcare Life Sciences). In these plasmids, overlap extension PCR was performed to induce the mutation in the UHM motif of SPF45 (pcDNA3-Flag-SPF45/UHMmt and pGEX6p2-SPF45/UHMmt), to delete the G-patch motif (pcDNA3-Flag-SPF45/∆G and pGEX6p2-SPF45/∆G), and to make these siRNA-resistant variants (pcDNA3-Flag-SPF45/siR, pcDNA3-Flag-SPF45/UHMmt/siR and pcDNA3-Flag-SPF45/∆G/siR).
Western blotting analyses. Protein samples were boiled with NuPAGE LDS sample buffer (Thermo Fisher Scientific), separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and the gel was electroblotted onto an Amersham Protran NC Membrane (GE Health Care Life Sciences). The following commercially available antibodies were used to detect targeted proteins: anti-SPF45 (Sigma-Aldrich), anti-SF3b155 (MBL Life Science), anti-U2AF 65 (Sigma-Aldrich), anti-U2AF 35 (Proteintech), anti-SF4 (Sigma-Aldrich), anti-U1-70K (Santa Cruz Biotechnology), anti-GAPDH (MBL Life Science) and anti-Flag (anti-DYKDDDDK tag; Wako). The anti-hPRP43 antibody was described previously 38 . Immuno-reactive protein bands were detected by the ECL system and visualized by imaging analyzer (ImageQuant LAS 500, GE Healthcare Life Sciences).
Splicing efficiency screening of siRNA library. HeLa cells were cultured in Dulbecco's modified Eagle's medium (Wako) supplemented with 10% fetal bovine serum. HeLa cells in 35-mm dishes were transfected with 100 pmol of each siRNA in the Stealth siRNA library targeting 154 human nuclear proteins (Invitrogen-Thermo Fisher Scientific) using Lipofectamine RNAiMax (Invitrogen-Thermo Fisher Scientific) according to the manufacturer's protocol.
At 48-96 h post-transfection, total RNAs were isolated from the siRNA-treated HeLa cells and splicing efficiency was analyzed by RT-PCR using a primer set targeting intron 7 of HNRNPH1 (Table S3 ). The PCR products were separated on 5% PAGE, visualized by imaging analyzer (ImageQuant LAS 500, GE Healthcare Life Sciences), and the unspliced pre-mRNA and spliced mRNA were quantified using NIH Image J software. See below for the detailed procedures. siRNA knockdown and splicing assays. HeLa cells and HEK293 cells (in 35-mm dishes) were transfected with 100 pmol siRNA using Lipofectamine RNAi max (Invitrogen-Thermo Fisher Scientific) according to manufacturer's protocol. At 72 h post-transfection, total RNAs were isolated from the siRNA-treated cells using a NucleoSpin RNA kit (Macherey-Nagel).
To check depletion of the siRNA-targeted proteins, transfected cells were suspended in Buffer D [20 mM HEPES (pH 7.9), 50 mM KCl, 0.2 mM EDTA, 20% glycerol], sonicated for 20 sec, centrifuged to remove debris, and the lysates were subjected to Western blotting (see above). The siRNAs for SPF45 siRNA#1, SPF45 siRNA#2, U2AF 65 siRNA#1 17 , hPRP43 siRNA#1 were purchased from Nippon Gene (Table S3 for the sequences).
To analyze endogenous splicing products derived from the HNRNPH1, RFC4, EML3, DUSP1, NFKBIA, MUS81, RECQL4 and MTA1 genes, total RNAs from siRNA-treated cells were reverse transcribed by PrimeScript II reverse transcriptase (Takara Bio) with oligo-dT and random primers, and the obtained cDNAs were analyzed by PCR using the specific primer sets (Table S3 ). The PCR products were resolved by 6% PAGE. Splicing products were quantified using NIH Image J software. All the experiments were independently repeated three times and the means and standard errors of the splicing efficiencies were calculated.
To analyze splicing products derived from mini-genes, SPF45-and U2AF 65 -depleted HeLa cells were transfected at 48 h and 68 h post-transfection, respectively, with 0.5 µg of mini-gene plasmid (Table S3 ) using lipofectamine 2000 reagent (Invitrogen-Thermo Fisher Scientific). These cells were incubated for 24 h and 4 h, respectively, prior to the extraction of RNAs (described above). To analyze splicing products from mini-genes, RT-PCR was performed with T7 primer and a specific primer for each mini-gene (Table S3 ). All the PCR products were analyzed by 6% PAGE and quantified (described above).
To perform rescue experiments, SPF45-depleted HeLa cells were transfected with 1 µg of pcDNA3-Flag-SPF45/siR, pcDNA3-Flag-SPF45/UHMmt/siR, or pcDNA3-Flag-SPF45/∆G/siR at 24 h post-transfection. After 48 h culture, total RNA and protein were isolated for RT-PCR and Western blotting, respectively (described above).
In this study, all the oligonucleotide primers were purchased (Fasmac ; Table S3 ) and all the PCRs were performed with Blend Taq polymerase (Toyobo Life Science).
High-throughput RNA sequencing (RNA-Seq) analyses. Six independent total RNAs derived from HEK293 cells, treated with three control siRNAs and three SPF45-targeted siRNAs, were prepared by NucleoSpin RNA kit (Macherey-Nagel). Then rRNA depletion was performed with the RiboMinus Eukaryote System v2 (Invitrogen-Thermo Fisher Scientific). RNA libraries were prepared using the NEBNext Ultra RNA Library Prep Kit for Illumina (New England Biolabs). These samples were sequenced on the high-throughput sequencing platform (HiSeq2500, Illumina) using a 100 bp single-end strategy.
The sequencing data was analyzed as previously described 39 . Obtained sequence reads were mapped onto the human genome reference sequences (hg19) using the TopHat version 2.1.1 (https://ccb.jhu.edu/software/tophat/index.shtml) and the mapped sequence reads, as BAM files, were assembled using Cufflinks version 2.2.1 (http://cufflinks.cbcb.umd.edu). Using the obtained Cufflinks GTF files as a reference, the BAM files were analyzed using rMATS version 3.2.0 (http://rnaseq-mats.sourceforge.net/) 40 to examine the changes of alternative splicing isoforms. Significant changes of splicing events were defined as when the false discovery rate (FDR) was calculated at less than 0.05.
The strengths of the 5¢ and 3¢ splice sites were calculated using MAXENT (http://hollywood.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html, http://hollywood.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq_acc.html) 41 , and branch point strength, PPT score and PPT length were calculated by SVM-BP finder software (http://regulatorygenomics.upf.edu/Software/SVM_BP/) 42 . The raw data from the RNA-Seq analysis have been deposited in the SRA database (https://www.ncbi.nlm.nih.gov/sra) under accession number GSE135128.
To analyze the sets of retained introns in U2AF 65 -and SF3b155-depleted HeLa cells, these RNA-Seq data were obtained from the GEO database (Accession numbers GSE65644 and GSE61603) 17, 43 .
Cellular formaldehyde-and UV-crosslinking followed by immunopreciptation assays. To detect Flag-SPF45 association to a pre-mRNA expressed from a reporter mini-gene, we performed formaldehyde crosslinking followed by immunoprecipitation as previously described 12 . Briefly, HEK293 cells (in 60-mm dishes) were co-transfected with pcDNA3-Flag-SPF45 and a mini-gene plasmid (pcDNA3-hnRNPH1, pcDNA3-EML3, pcDNA3-MUS81 or pcDNA3-AdML) using Lipofectamine 2000 reagent (Invitrogen-Thermo Fisher Scientific). At 48 h post-transfection, cells were harvested, washed with cold PBS buffer, and fixed with 0.2% formaldehyde for 10 min. The fixation was quenched in 0.15 M glycine (pH 7.0) and cells were washed with PBS. Immunoprecipitations were performed using anti-Flag antibody-conjugated beads to analyze pre-mRNA, from the mini-gene, associated with Flag-SPF45.
To detect endogenous U2AF 65 -and SF3b155-association to a pre-mRNA expressed from a reporter mini-gene, we performed UV crosslinking followed by immunoprecipitation as previously described 44, 45 . PBS-washed HEK293 cells were irradiated with 254-nm UV light on ice. The collected cells were lysed and immunoprecipitated with anti-U2AF 65 and anti-SF3b155 antibodies.
Immunoprecipitated RNAs were extracted with Trizol reagent (Invitrogen-Thermo Fisher Scientific). The isolated RNAs were reverse-transcribed using PrimeScript II reverse transcriptase (Takara Bio) with SP6 primer, and qPCRs were performed using specific primer sets (Table S3 ).
Biotinylated RNA pull-down assays. Nuclear extracts were prepared from HEK293 cells transfected with control siRNA or SPF45 siRNA according to the small-scale preparation procedure 46 . Biotin-labeled HNRNPH1 and AdML pre-mRNAs were transcribed with a MEGAscript T7 transcription kit (Invitrogen-Thermo Fisher Scientific) according to the manufacturer's instructions.
The biotinylated pre-mRNA (10 pmol) was immobilized with 5 µL of Dynabeads MyOne StreptavidinT1 magnetic beads (Invitrogen-Thermo Fisher Scientific) according to the manufacturer's instruction. The immobilized pre-mRNA beads were incubated at 30°C for 15 min in 30 µL reaction mixture containing 30% nuclear extract, RNase inhibitor (Takara Bio) and nuclease-free water. Then NET2 buffer [50mM Tris (pH7.5), 150 mM NaCl and 0.05% Nonidet P-40] was added to a final volume of 700 µL and incubated at 4°C for 1 h. The incubated beads were washed six times with cold NET2 buffer and boiled in SDS-PAGE sample buffer to analyze by Western blotting (described above).
GST pull-down assays.
GST-SPF45, GST-SPF45/UHMmt, or GST-SPF45/∆G were expressed in E. coli BL21(DE3) CodonPlus (DE3) competent cells (Stratagene-Agilent) and the GST-tagged recombinant proteins were checked by SDS-PAGE followed by Coomassie Blue staining. Induction was carried out at 37°C for 3 h. The GST-proteins were purified using Glutathione Sepharose 4B (GE Healthcare Life Sciences) according to the manufacturer's protocol.
The recombinant GST-SPF45 proteins (5 µg) were incubated at 30°C for 15 min in 100 µL mixture containing 30% HeLa cell nuclear extract. After RNase A treatment, NET2 buffer was added to a final volume of 1 mL with 20 µL of Glutathione Sepharose 4B or SF3b155aantibody conjugated with Protein G Sepharose (GE Healthcare Life Sciences) and incubated at 4°C for 3 h. The incubated beads were washed six times with cold NET2 buffer and boiled in SDS-PAGE sample buffer to analyze by Western blotting (described above).
Immunofluorescence microscopic assays. Immunofluorescence microscopic assays of ectopically expressed Flag-tagged SPF45 proteins were performed as essentially described previously 45 .
HeLa cells (in 35-mm dishes) were transfected with 1 µg of pcDNA3-Flag-SPF45/siR, pcDNA3-Flag-SPF45/UHMmt/siR, or pcDNA3-Flag-SPF45/∆G/siR using lipofectamine 2000 reagent (Invitrogen-Thermo Fisher Scientific). At 48 h post-transfection, cells were fixed with 3% formaldehyde/PBS, permeabilized with 0.1% Triton X-100/PBS, blocked with 5% skimmed milk/PBS and then incubated with primary antibodies in 2% skimmed milk/PBS for 0.5 h. After three washes with PBS, cells were incubated with Alexa Fluor 488 or Alexa Fluor 568 secondary antibody (Invitrogen-Thermo Fisher Scientific) and then washed 5 times with PBS. DNA in cells was counter-stained with 4', 6-diamidino-2-phenylindole (DAPI). The images were analyzed by fluorescence microscope (Olympus).
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Table S2
(Uploaded in a separate Excel file) In cellulo splicing assays of the indicated three short introns using RT-PCR (see also Figs. 1, 2c ). Means ± SE are given for three independent experiments (*P < 0.05, **P < 0.005). b, The same in cellulo splicing assays were performed using SPF45-knockdown HEK293 cells. Means ± SE are given for three independent experiments (*P < 0.05, **P < 0.005). In cellulo splicing assays of EML3-intron 17 and MUS81-intron 13 pre-mRNAs were performed using control siRNA-and SPF45 siRNA-treated HeLa cells (see Fig. 1 for the depletion efficiency of SPF45). See Fig. 3 for splicing assays with HNRNPH1-intron 7 and AdML-intron 1 pre-mRNAs). Means ± SE are given for three independent experiments (*P < 0.05, **P < 0.005). In cellulo splicing assays of the indicated three short introns using RT-PCR (see also Fig. S1 ). Means ± SE are given for three independent experiments (*P < 0.05, n.s. P > 0.05). b, HeLa cells were transfected with control siRNA (Ctl) and siRNA targeting hPRP43. See above for Western blotting and in cellulo splicing assays. c, HeLa cells were transfected with control siRNA (Ctl) and siRNA targeting SF4. See above for Western blotting and in cellulo splicing assays. a, Schematic structures of SPF45 and the induced mutations in the indicated expression plasmids. The DàK mutation in SPF45/UHMmt, whose protein cannot binds ULM, is highlighted in blue. The target of SPF45-siRNA#2 is depicted and introduced five silent siRNA-resistant mutations were highlighted in red. b, HeLa cells were transfected with Flag-SPF45/siR, Flag-SPF45/UHMmt/siR, and Flag-SPF45/∆G/siR expression plasmids and their subcellular localizations were examined by immunofluorescence microscopy using indicated antibodies. Cells were also stained with DAPI to detect nuclei.
